
The FDA's Vaccines and Related Biological Products Advisory Committee voted to recommend updating the COVID-19 vaccine to include a SARS-CoV-2 JN.1 lineage strain, citing the current vaccine's ineffectiveness against emerging variants. Despite the absence of safety data, the committee emphasized the importance of vaccine effectiveness, while noting the potential for rapid variant evolution which might impact vaccine efficacy. Manufacturers like Moderna, Pfizer, and Novavax presented promising data for their new vaccine candidates, with an emphasis on preparedness to meet the FDA's upcoming strain decision.
.png)
Learn about the ACIP recommendation for Pfizer's Abrysvo RSV vaccine in pregnant women, the controversy surrounding its testing, and the potential impact on preterm births – all in our eye-opening article on RSV vaccination strategies.

Learn about CDC's treatment of the RSV drug nirsevimab as a vaccine and potential impacts to vaccine mandates, tracking and injury compensation.

Learn about ACIP's October 2022 vote to add COVID-19 to the childhood vaccination schedule.

Learn about SARS-CoV-2, COVID disease and the COVID vaccine being recommended for children in the U.S. and major questions about mRNA COVID vaccine.

Actualización del Comité Consultivo Nacional sobre VacunasPublicado originalmente February 2017A medida que transcurre el año 2017, los comités consultivos federales--el Comité Asesor sobre Prácticas de Inmunización (ACIP), el Comité Consultivo...

Discover why more and more parents today question and mistrust vaccine science, policy and law.

NVIC questions the government's initiative to administer swine flu vaccine to all public school children in the Fall of 2009.

Learn about contamination of rotavirus vaccines with animal virus DNA that was not detected pre or post-licensure - a wake up call for industry and government.
NVIC to FDA: mRNA COVID-19 Shots Should Not Be Recommended for Anyone
On May 23, 2025, NVIC submitted a written public comment to the US Food and Drug Administration’s Vaccines & Related Biological Products Advisory Committee (VRBPAC) signed by two former consumer...